Depression is common in people with multiple sclerosis (MS), and a new study shows that people with both conditions may be more likely to die over the next decade than people with just one or neither condition. The study is published in the September 1, 2021, online issue of Neurology, the medical journal of the […]
Home »
Is the Delta Plus COVID-19 variant a new concern?
India, already hit hard by the Delta variant of COVID-19, has labeled a closely related new variant—dubbed “Delta Plus”—as a “variant of concern.” But some epidemiologists in India and abroad say there is not enough data yet to warrant broader cautions about the variant, CBS News reported. Delta Plus cases are rising in India, and […]
FDA issues EUA to baricitinib plus remdesivir for COVID-19
(HealthDay)—Emergency use authorization was issued for baricitinib in combination with remdesivir for hospitalized patients with COVID-19, the U.S. Food and Drug Administration announced Thursday. The EUA for the combination treatment applies to hospitalized patients ages 2 years and older with suspected or laboratory-confirmed COVID-19 who require supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation. […]
Rituximab plus lenalidomide effective in follicular lymphoma
(HealthDay)—Rituximab plus lenalidomide has similar efficacy to rituximab plus chemotherapy among patients with previously untreated follicular lymphoma, according to a study published in the Sept. 6 issue of the New England Journal of Medicine. Franck Morschhauser, M.D., Ph.D., from the University of Lille in France, and colleagues conducted an international, randomized phase 3 trial to […]